Physician

Sayed Monis, M.D.

According to 2025 Medicare claims, Sayed Monis, M.D. (NPI: 1942480231) practices neurology in the El Centro, CA market, with the plurality of this provider's patient population coming from Imperial, CA. This provider's primary affiliated billing organization is NEURO SPINE AND HEADACHE PAIN MANAGEMENT CENTER (NPI: 1770808883; TIN: 264068488) and primary practice location at 92227-7714.

Monis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,238 traditional Medicare patients, billed 25,205 HCPCS/CPT codes, and received $2,281,283 in Medicare payments. The top billing code was 95816 (Measurement of brain wave activity (eeg), awake and drowsy). Part D data shows 702 prescription claims across 282 beneficiaries totaling $62,295 in drug costs, led by Namzaric (Memantine Hcl/Donepezil Hcl). 2023 DME data shows 13 claims. Open Payments data shows 26 records totaling $937. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $908,234 to $2,281,283. In contrast, Part D prescription costs have fallen sharply in recent years, from $884,675 to $62,295. For DME billing, this smaller-volume category started with an early spike, then settled into a lower baseline, moving from $14,685 to $541.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	865	21,223	$908,234
2016	965	25,016	$993,490
2017	1,182	33,130	$1,448,592
2018	1,583	34,049	$1,820,596
2019	2,015	47,333	$2,275,136
2020	2,006	44,313	$1,960,170
2021	2,180	27,476	$2,304,225
2022	2,182	24,124	$2,705,428
2023	2,195	25,263	$2,799,025
2024	2,238	25,205	$2,281,283

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	769	7,637	$884,675
2016	869	8,935	$840,750
2017	925	8,111	$877,694
2018	1,228	12,032	$1,454,569
2019	1,640	15,193	$1,622,764
2020	1,805	18,842	$2,112,713
2021	2,054	21,960	$2,662,217
2022	1,876	15,072	$1,851,450
2023	646	2,434	$525,227
2024	282	702	$62,295

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	32	43	$16,237
2017	14	32	$10,767
2018	N/R	68	$1,347
2019	15	26	$18,040
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	14	14	$1,644
2023	13	13	$1,643
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95816	Measurement of brain wave activity (eeg), awake and drowsy	998	1,030	$294
93890	Ultrasound of within the brain blood flow following medication	685	690	$172
93892	Ultrasound of within the brain blood flow for blood clots	685	690	$125
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,968	6,124	$57
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	1,809	5,541	$42

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Namzaric	Memantine Hcl/Donepezil Hcl	40	1,440	$27,926
Memantine Hcl	Memantine Hcl	76	2,403	$1,014
Carbidopa-Levodopa	Carbidopa/Levodopa	32	1,235	$745
Pregabalin	Pregabalin	25	945	$547
Levetiracetam	Levetiracetam	20	678	$375

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	26	$937	Nevro Corp.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sayed Monis, M.D.?

Tedicare shows public-source Medicare data for Sayed Monis, M.D. (NPI 1942480231), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sayed Monis, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sayed Monis, M.D.?

Sayed Monis, M.D. is linked to NEURO SPINE AND HEADACHE PAIN MANAGEMENT CENTER (billing NPI 1770808883) in the available physician profile data.

Does Sayed Monis, M.D. have Open Payments data?

Sayed Monis, M.D. has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.